KETOROLAC TROMETHAMINE INJECTION, USP
JUNO PHARMA CANADA INC.
Quick answers
Is there a shortage of KETOROLAC TROMETHAMINE INJECTION, USP in Canada?
No. There is no current shortage of KETOROLAC TROMETHAMINE INJECTION, USP 30MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
TORADOL IM 30MG/ML
HOFFMANN-LA ROCHE LIMITED
ACULAR
ABBVIE CORPORATION
TORADOL INJ 10MG/ML
SYNTEX INC.
TORADOL IM
ATNAHS PHARMA UK LIMITED
KETOROLAC TROMETHAMINE INJECTION USP
SABEX INC
ACUVAIL
ABBVIE CORPORATION
DIN
02443376
Strength
30MG
Dosage Form
Solution
Route
Intramuscular
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from JUNO PHARMA CANADA INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
100MG · DIN 02561557
0.01% · DIN 02529580
100MG · DIN 00821780
100MCG · DIN 02489244
250MCG · DIN 02538377
50MG · DIN 02460947
70MG · DIN 02460955
100MCG · DIN 02467976
200MCG · DIN 02487365
400MCG · DIN 02487373
250MG · DIN 02544083
2MG · DIN 02540827